No title
Adaptive data-dependent allocation designs are used in phase III clinical trials having two or more competing treatments with sequential entrance of patients, in order to allocate a larger number of patients to the better treatment. The odds ratio is a popular concept for biomedical practitioners; hence, odds-ratio-based adaptive designs could be very useful in practice. Rosenberger et al. (2001)
